Genetic subgroup learnings from MMPOWER-3 trial: Elamipretide improved six-minute walk test in individuals with mtDNA replisome disorders

Karaa, A., Mancuso, M., Cohen, B., Falk, M., Goldstein, A., Koenig, M. K., Hirano, M., Vissing, J., & Brown, D. A. (2022). Genetic subgroup learnings from MMPOWER-3 trial: Elamipretide improved six-minute walk test in individuals with mtDNA replisome disorders. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1863, 148868. https://doi.org/10.1016/j.bbabio.2022.148868

Authors:

Amel Karaa

Michelangelo Mancuso

Bruce M. Cohen

Marni J. Falk

Amy Goldstein

Mary Kay Koenig

Michio Hirano

John Vissing

David A. Brown

Affiliated Authors:

Michio Hirano